NK cell-associated LncRNA signature predicts prognosis and immune landscape in hepatocellular carcinoma.

For female patients and late-stage patients, although not statistically significant, there is a clear trend that the high-risk subgroup holds a weaker existence (Fig. 6 F).

also in 19,460 other papers